Our mission is to develop transformative medicines for neurological and neuropsychiatric disorders, deploying AI to uncover promising molecules from biodiversity with prior evidence of human efficacy and tolerability.
We are scientists, entrepreneurs, researchers, biologists, patent specialists and executives. Together we work to create a healthier world inspired by the therapeutic potential of nature and the power of technology. At the heart of this is our passion for progress and an unbridled curiosity.
The plant, the fungal and the animal kingdoms have co-evolved over hundreds of millions of years yielding innumerable symbiotic relationships at the molecular and protein level waiting to be discovered and adapted for the development of human medicines. This strategy to develop medicines inspired by nature, harnessing AI to unlock nature's therapeutic potential, should significantly improve the odds of drug development to successfully bring novel CNS medications to patients in need.
Co-Founder and CEO Pangea Bio
The natural world is the inspiration for our drug discovery and development work. Some natural remedies have been used by indigenous communities for centuries. We are fully committed to comply with the Convention on Biological Diversity and the Nagoya protocol on Access and Benefit Sharing. We strive to meet the highest standards in social and environmental impact and we have applied to become a certified B Corp.